Vascular and Interventional Radiology Center, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Hospital/The Johns Hopkins University, 1800 Orleans Street, Zayed Tower 7203, Baltimore, MD, 21287, USA.
Evidera, Bethesda, MD, USA.
Qual Life Res. 2020 Jun;29(6):1707-1719. doi: 10.1007/s11136-020-02435-3. Epub 2020 Feb 4.
To determine important symptoms and functional effects of venous malformations (VMs) to assess the content validity of commonly used patient-reported outcome (PRO) measures for use with VM patients.
This cross-sectional, qualitative study involved cognitive interviews with participants with VM aged ≥ 14 years. From February to June 2016, 11 participants (8 female) with a mean (± standard deviation) age of 31 ± 15 years were recruited from three clinical sites. The following subgroups were evaluated: 5 adults (aged ≥ 18) with trunk/extremity VMs; 3 adolescents (aged 14-17) with trunk/extremity VMs; and 3 adults with head/neck VMs. We evaluated the content validity of the Worst Pain Numeric Rating Scale (NRS), Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Interference 8-item short form, and PROMIS Physical Function 8-item short form.
The most common participant-reported VM symptoms were swelling (n = 10), skin discoloration (n = 8), acute episodic pain (n = 8), chronic pain (n = 7), numbness (n = 7), and tingling/burning (n = 6). Participants reported that VMs affected their physical function (n = 10), appearance (n = 10), relationships/social activities (n = 7), and emotional health (n = 3). The Worst Pain NRS and PROMIS Pain Interference measures were relevant to all participants' VM experience. Only adults with head/neck VMs found the PROMIS Physical Function measure to be irrelevant. The assessed PRO measures did not address several symptoms commonly reported by VM patients (swelling, skin discoloration, numbness, and appearance).
These results suggest that several VM symptoms are not assessed fully by commonly used PRO measures, and that the relevance of functional limitation questions may vary by VM location.
确定静脉畸形(VM)的重要症状和功能影响,以评估常用于 VM 患者的患者报告结局(PRO)测量的内容效度。
本横断面、定性研究包括对年龄≥14 岁的 VM 患者进行认知访谈。2016 年 2 月至 6 月,从三个临床地点招募了 11 名参与者(8 名女性),平均(±标准差)年龄 31±15 岁。评估了以下亚组的内容效度:5 名成人(年龄≥18 岁),VM 位于躯干/四肢;3 名青少年(年龄 14-17 岁),VM 位于躯干/四肢;3 名成人,VM 位于头颈部。我们评估了最差疼痛数字评定量表(NRS)、患者报告的结局测量信息系统(PROMIS®)疼痛干扰 8 项短表和 PROMIS 身体功能 8 项短表的内容效度。
参与者最常报告的 VM 症状为肿胀(n=10)、皮肤变色(n=8)、急性发作性疼痛(n=8)、慢性疼痛(n=7)、麻木(n=7)和刺痛/烧灼感(n=6)。参与者报告 VM 影响他们的身体功能(n=10)、外观(n=10)、人际关系/社会活动(n=7)和情绪健康(n=3)。最差疼痛 NRS 和 PROMIS 疼痛干扰测量与所有参与者的 VM 体验相关。只有头颈部 VM 的成人认为 PROMIS 身体功能测量不相关。评估的 PRO 测量方法没有涉及 VM 患者常报告的几种症状(肿胀、皮肤变色、麻木和外观)。
这些结果表明,几种 VM 症状没有被常用的 PRO 测量方法充分评估,且功能受限问题的相关性可能因 VM 位置而异。